Results 41 to 50 of about 806 (158)

Ten-year Follow-up Study of Grenz Ray Treatment for Lentigo Maligna and Early Lentigo Maligna Melanoma

Acta Dermato-Venereologica, 2020
Radiotherapy is often used to treat lentigo maligna. However, the long-term efficacy and safety of radiotherapy approaches have not been thoroughly evaluated.
Iara R.T. Drakensjö, Einar Rosen, Margareta Frohm Nilsson, Ada Girnita   +3 more
doaj   +1 more source

Chondrosarcomatous Differentiation in a Large Malignant Melanoma of the Scalp

Case Reports in Medicine, 2016
Background. Divergent differentiation in malignant melanoma is a rare phenomenon, which can lead to delayed diagnosis or misdiagnosis, impacting upon patient treatment and outcome, as well as the understanding of tumour behaviour. Case.
Colin S. Alderson, Helen E. Douglas, Rebecca Rollett, Bipin Mathew, Paolo Matteucci   +4 more
doaj   +1 more source

Multiclass convolutional neural network vs. 96 dermatologists in skin lesion diagnosis, an international study

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Summary Background and objectives Artificial intelligence was shown to improve diagnostic accuracy for skin cancer detection. While most clinically approved models provide binary “benign/malignant” classifications, multiclass predictions may offer greater clinical utility.
Katharina Susanne Kommoss, Julia Katharina Winkler, Anastasia Sophie Vollmer, Christine Mueller‐Christmann, Ferdinand Toberer, Wilhelm Stolz, Teresa Kraenke, Rainer Hofmann‐Wellenhof, Andreas Blum, Alexander Enk, Albert Rosenberger, Holger Andreas Haenssle   +11 more
wiley   +1 more source

Periocular Lentigo Maligna: To Treat or Not to Treat?

Vision Pan-America, 2014
Lentigo maligna (LM) affecting the periocular skin represents a challenge in its diagnosis and management. LM has a very slow rate of malignant transformation; however, with our aging population the progression towards malignant melanoma is concerning ...
Alison Gail Kartush, Son T Ho, Alejandra A. Valenzuela   +2 more
doaj   +1 more source

Use of the “spaghetti” technique for surgical treatment of lentigo maligna [PDF]

Revista Brasileira de Cirurgia Plástica, 2019
Lentigo maligna (LM) is a melanoma in situ that commonly presents as a macula with progressive and irregularly pigmented growth, especially in the face of elderly people with sun-damaged skin.
Gabriela Suemi Shimizu, Farid Bark Hamdar, Claudio Henrique Santana Tavares dos-Santos, Luiz Augusto Daloia Souza, Fernando Henrique Sgarbi Parro, Ivan Dunshee de Abranches Oliveira Santos, Christiane Steponavicius Sobral, Eduard René Brechtbühl   +7 more
doaj   +1 more source

Age‐related dermatoscopic features of excised melanomas versus nevi in 832 high risk patients

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Summary Background and objectives Melanocytic nevi show distinct age‐related dermoscopic patterns. However, data on age‐related patterns of melanomas are lacking. This study aimed to identify age‐related static and dynamic dermoscopic patterns of melanomas. Patients and methods Explorative cross‐sectional cohort study between October 1996 and May 2012,
Jana Burghaus‐Zhang, Julia Katharina Winkler, Katharina Susanne Kommoss, Anastasia Sophie Vollmer, Alexander Enk, Timo Buhl, Holger Andreas Haenssle   +6 more
wiley   +1 more source

Rapid recurrence of Lentigo Maligna Melanoma – A case report

JPRAS Open, 2017
Lentigo Maligna Melanoma (LMM) is a slow-growing variant of melanoma arising in a premalignant lesion (LM), which tends to appear on the sun-exposed skin of elderly people.
A. Abdaal, R.D. Price, A.J. Durrani
doaj   +1 more source

International Dermoscopy Society consensus recommendations for the management of lentigo maligna

Journal of the European Academy of Dermatology and Venereology, EarlyView.
Lentigo maligna (LM) poses diagnostic and therapeutic challenges amid rising incidence and limited high‐quality evidence. This international expert consensus provides pragmatic, evidence‐based and expertise‐informed guidance on LM diagnosis and management.
Ana‐Maria Forsea, Riccardo Pampena, Bengu Nisa Akay, Zoe Apalla, Giuseppe Argenziano, Giulia Briatico, Ralph Braun, Horacio Cabo, Raul Cabrera, Cristina Carrera, Elisa Cinotti, Claudio Conforti, Enzo Errichetti, Gerardo Ferrara, Roberta Giuffrida, Stefania Guida, Pascale Guitera, Allan C. Halpern, Stephen Heyes, Rainer Hofmann‐Wellenhof, Angela M. Hong, Natalia Jaimes, Raimonds Karls, Harald Kittler, Teresa Kränke, Konstantinos Liopyris, Jie Liu, Caterina Longo, Josep Malvehy, Ashfaq A. Marghoob, Hoda Moneib, David Moreno Ramirez, Elvira Moscarella, Eduardo Nagore, Cristian Navarrete‐Dechent, John Paoli, Giovanni Pellacani, Ketty Peris, Susana Puig, Cliff Rosendahl, Lidia Rudnicka, Ahmed Sadek, Philippe Saiag, Gabriel Salerni, Alon Scope, Hans Peter Soyer, Michela V. Starace, Wilhelm Stolz, David L. Swanson, Luc Thomas, Philipp Tschandl, Iris Zalaudek, Aimilios Lallas   +52 more
wiley   +1 more source

The CUBED Versus ABCDE Recognition Tools in the Detection of Malignant Melanomas Arising in the Foot: An Analysis of Four Recent Case Studies in a Single NHS Community Trust

Journal of Foot and Ankle Research, Volume 19, Issue 2, June 2026.
ABSTRACT Background Melanoma of the foot and nail unit carries a worse prognosis than cutaneous melanoma elsewhere because lesions are frequently hidden, misdiagnosed, and therefore diagnosed at more advanced stages. Traditional ABCDE criteria are often insufficient for foot and nail presentations; the CUBED recognition tool was developed to improve ...
Amy Sherratt, Emily Vaughan, Nekita Huckerby, Hannah Winn, Margaret Swithenbank   +4 more
wiley   +1 more source

Benefit of immune checkpoint inhibitors as adjuvant treatment for acral melanomas

Journal of the European Academy of Dermatology and Venereology, Volume 40, Issue 6, Page 1069-1077, June 2026.
When questioning the effectiveness of adjuvant immunotherapy for acral melanomas, we found no clinical benefit to the adjuvant proposal, despite the maintenance of adverse effects. Abstract Background Solar factors play no role in the development of acral melanoma (AM). AM is characterized by low cumulative solar damage (low CSD).
Damien Sanogo, Romain Levard, Julie Cassecuel, Amir Khammari, Gaelle Quereux, Florent Grange, Henri Montaudié, Florence Brunet‐Possenti, Justine Lavaud, Marie‐Thérèse Leccia, Géraldine Jeudy, Anne Dompmartin, Brigitte Dreno, Jean‐Matthieu L’Orphelin   +13 more
wiley   +1 more source